219 related articles for article (PubMed ID: 20717106)
1. 5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis.
Ford AC; Khan KJ; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Mar; 106(3):413-20. PubMed ID: 20717106
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis.
Ford AC; Kane SV; Khan KJ; Achkar JP; Talley NJ; Marshall JK; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):617-29. PubMed ID: 21407190
[TBL] [Abstract][Full Text] [Related]
3. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
Gordon M; Taylor K; Akobeng AK; Thomas AG
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010233. PubMed ID: 25081347
[TBL] [Abstract][Full Text] [Related]
4. Aminosalicylates for induction of remission or response in Crohn's disease.
Lim WC; Hanauer S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400
[TBL] [Abstract][Full Text] [Related]
5. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.
Gjuladin-Hellon T; Gordon M; Iheozor-Ejiofor Z; Akobeng AK
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD008414. PubMed ID: 31220875
[TBL] [Abstract][Full Text] [Related]
6. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.
Gordon M; Naidoo K; Thomas AG; Akobeng AK
Cochrane Database Syst Rev; 2011 Jan; (1):CD008414. PubMed ID: 21249709
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis.
Ford AC; Achkar JP; Khan KJ; Kane SV; Talley NJ; Marshall JK; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):601-16. PubMed ID: 21407188
[TBL] [Abstract][Full Text] [Related]
8. Interventions for prevention of post-operative recurrence of Crohn's disease.
Doherty G; Bennett G; Patil S; Cheifetz A; Moss AC
Cochrane Database Syst Rev; 2009 Oct; (4):CD006873. PubMed ID: 19821389
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of oral vs. topical, or combined oral and topical 5-aminosalicylates, in Ulcerative Colitis: systematic review and meta-analysis.
Ford AC; Khan KJ; Achkar JP; Moayyedi P
Am J Gastroenterol; 2012 Feb; 107(2):167-76; author reply 177. PubMed ID: 22108446
[TBL] [Abstract][Full Text] [Related]
10. Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.
Derwa Y; Gracie DJ; Hamlin PJ; Ford AC
Aliment Pharmacol Ther; 2017 Aug; 46(4):389-400. PubMed ID: 28653751
[TBL] [Abstract][Full Text] [Related]
11. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease.
Akobeng AK; Gardener E
Cochrane Database Syst Rev; 2005 Jan; (1):CD003715. PubMed ID: 15674913
[TBL] [Abstract][Full Text] [Related]
12. Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn's disease.
Steinhart AH; Forbes A; Mills EC; Rodgers-Gray BS; Travis SP
Aliment Pharmacol Ther; 2007 Jun; 25(12):1389-99. PubMed ID: 17539978
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis.
Ford AC; Bernstein CN; Khan KJ; Abreu MT; Marshall JK; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):590-9; quiz 600. PubMed ID: 21407179
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
Ford AC; Sandborn WJ; Khan KJ; Hanauer SB; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):644-59, quiz 660. PubMed ID: 21407183
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials.
Carla-Moreau A; Paul S; Roblin X; Genin C; Peyrin-Biroulet L
Dig Liver Dis; 2015 Mar; 47(3):191-6. PubMed ID: 25488057
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.
Khan KJ; Ullman TA; Ford AC; Abreu MT; Abadir A; Marshall JK; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):661-73. PubMed ID: 21407187
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis.
Coward S; Kuenzig ME; Hazlewood G; Clement F; McBrien K; Holmes R; Panaccione R; Ghosh S; Seow CH; Rezaie A; Kaplan GG
Inflamm Bowel Dis; 2017 Mar; 23(3):461-472. PubMed ID: 28146003
[TBL] [Abstract][Full Text] [Related]
18. Once-daily dosing vs. conventional dosing schedule of mesalamine and relapse of quiescent ulcerative colitis: systematic review and meta-analysis.
Ford AC; Khan KJ; Sandborn WJ; Kane SV; Moayyedi P
Am J Gastroenterol; 2011 Dec; 106(12):2070-7; quiz 2078. PubMed ID: 21894226
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis: a meta-analysis.
Ford AC; Khan KJ; Sandborn WJ; Hanauer SB; Moayyedi P
Clin Gastroenterol Hepatol; 2012 May; 10(5):513-9. PubMed ID: 22083024
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
Khan KJ; Dubinsky MC; Ford AC; Ullman TA; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):630-42. PubMed ID: 21407186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
